Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in immunotherapeutic targets for childhood cancers: A focus on glypican-2 and B7-H3. | Pharmacol Ther | 2021 | 33992682 | PubTator, text mining | PubMed |
| Nanomaterial-based delivery vehicles for therapeutic cancer vaccine development. | Cancer Biol Med | 2021 | 33979069 | PubTator, text mining | PubMed |
| Sex differences in pharmacological treatment of major depressive disorder: results from the AMSP pharmacovigilance program from 2001 to 2017. | J Neural Transm (Vienna) | 2021 | 33977402 | PubTator, text mining | PubMed |
| Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination. | Nat Commun | 2021 | 33976179 | PubTator, text mining | PubMed |
| CAR T-cell therapy for pleural mesothelioma: Rationale, preclinical development, and clinical trials. | Lung Cancer | 2021 | 33972125 | PubTator, text mining | PubMed |
| Antitumor effects of iPSC-based cancer vaccine in pancreatic cancer. | Stem Cell Reports | 2021 | 33961792 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| Oral Unsaturated Fat Load Impairs Postprandial Systemic Inflammation in Primary Hypercholesterolemia Patients. | Front Pharmacol | 2021 | 33959024 | PubTator, text mining | PubMed |
| Nanoparticle-based applications for cervical cancer treatment in drug delivery, gene editing, and therapeutic cancer vaccines. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2021 | 33942532 | PubTator, text mining | PubMed |
| Monitoring T Cells Responses Mounted by Therapeutic Cancer Vaccines. | Front Mol Biosci | 2021 | 33937323 | PubTator, text mining | PubMed |
| Expression and Prognostic Significance of Cancer/Testis Antigens, MAGE-E1, GAGE, and SOX-6, in Glioblastoma: An Immunohistochemistry Evaluation. | Iran J Pathol | 2021 | 33936223 | PubTator, text mining | PubMed |
| Preclinical Models of Cancer Therapy-Associated Cardiovascular Toxicity: A Scientific Statement From the American Heart Association. | Circ Res | 2021 | 33934611 | PubTator, text mining | PubMed |
| Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies. | Circ Res | 2021 | 33934609 | PubTator, text mining | PubMed |
| Immunological and functional aspects of MAGEA3 cancer/testis antigen. | Adv Protein Chem Struct Biol | 2021 | 33931137 | PubTator, text mining | PubMed |
| T-Cell Receptor Therapy in the Treatment of Ovarian Cancer: A Mini Review. | Front Immunol | 2021 | 33927729 | PubTator, text mining | PubMed |
| Prognostic and Predictive Biomarkers in Stage III Melanoma: Current Insights and Clinical Implications. | Int J Mol Sci | 2021 | 33925387 | PubTator, text mining | PubMed |
| Oncolytic Virotherapy for Cancer: Clinical Experience. | Biomedicines | 2021 | 33924556 | PubTator, text mining | PubMed |
| Anti-PD-1/PD-L1 Based Combination Immunotherapy to Boost Antigen-Specific CD8+ T Cell Response in Hepatocellular Carcinoma. | Cancers (Basel) | 2021 | 33923463 | PubTator, text mining | PubMed |
| Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines. | Vaccines (Basel) | 2021 | 33918072 | PubTator, text mining | PubMed |
Combined Assessment of Immune Checkpoint Regulator VISTA on Tumor-Associated Immune Cells and Platelet-to-Lymphocyte Ratio Identifies Advanced Germ Cell Tumors with Higher Risk of Unfavorable Outcomes. | Cancers (Basel) | 2021 | 33916925 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=44